Cargando…
Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19
BACKGROUND: Given the sparse data on vitamin D status in pediatric COVID-19, we investigated whether vitamin D deficiency could be a risk factor for susceptibility to COVID-19 in Egyptian children and adolescents. We also investigated whether vitamin D receptor (VDR) FokI polymorphism could be a gen...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461391/ https://www.ncbi.nlm.nih.gov/pubmed/36085364 http://dx.doi.org/10.1038/s41390-022-02275-6 |
_version_ | 1784786962211667968 |
---|---|
author | Zeidan, Nancy M. S. Lateef, Hanan M. Abd El Selim, Dalia M. Razek, Suzan A. Abd-Elrehim, Ghada A. B. Nashat, Mohamed ElGyar, Noha Waked, Nevin M. Soliman, Attia A. Elhewala, Ahmed A. Shehab, Mohamed M. M. Ibraheem, Ahmed A. A. Shehata, Hassan Yousif, Yousif M. Akeel, Nagwa E. Hashem, Mustafa I. A. Ahmed, Amani A. Emam, Ahmed A. Abdelmohsen, Mohamed M. Ahmed, Mohamed F. Saleh, Ahmed S. E. Eltrawy, Heba H. Shahin, Gehan H. Nabil, Rehab M. Hosny, Thoraya A. Abdelhamed, Mohamed R. Afify, Mona R. Alharbi, Mohanned T. Nagshabandi, Mohammed K. Tarabulsi, Muyassar K. Osman, Sherif F. Abd-Elrazek, Amal S. M. Rashad, Manal M. El-Gaaly, Sonya A. A. Gad, Said A. B. Mohamed, Mohamed Y. Abdelkhalek, Khalil Yousef, Aly A. |
author_facet | Zeidan, Nancy M. S. Lateef, Hanan M. Abd El Selim, Dalia M. Razek, Suzan A. Abd-Elrehim, Ghada A. B. Nashat, Mohamed ElGyar, Noha Waked, Nevin M. Soliman, Attia A. Elhewala, Ahmed A. Shehab, Mohamed M. M. Ibraheem, Ahmed A. A. Shehata, Hassan Yousif, Yousif M. Akeel, Nagwa E. Hashem, Mustafa I. A. Ahmed, Amani A. Emam, Ahmed A. Abdelmohsen, Mohamed M. Ahmed, Mohamed F. Saleh, Ahmed S. E. Eltrawy, Heba H. Shahin, Gehan H. Nabil, Rehab M. Hosny, Thoraya A. Abdelhamed, Mohamed R. Afify, Mona R. Alharbi, Mohanned T. Nagshabandi, Mohammed K. Tarabulsi, Muyassar K. Osman, Sherif F. Abd-Elrazek, Amal S. M. Rashad, Manal M. El-Gaaly, Sonya A. A. Gad, Said A. B. Mohamed, Mohamed Y. Abdelkhalek, Khalil Yousef, Aly A. |
author_sort | Zeidan, Nancy M. S. |
collection | PubMed |
description | BACKGROUND: Given the sparse data on vitamin D status in pediatric COVID-19, we investigated whether vitamin D deficiency could be a risk factor for susceptibility to COVID-19 in Egyptian children and adolescents. We also investigated whether vitamin D receptor (VDR) FokI polymorphism could be a genetic marker for COVID-19 susceptibility. METHODS: One hundred and eighty patients diagnosed to have COVID‐19 and 200 matched control children and adolescents were recruited. Patients were laboratory confirmed as SARS-CoV-2 positive by real-time RT-PCR. All participants were genotyped for VDR Fok1 polymorphism by RT-PCR. Vitamin D status was defined as sufficient for serum 25(OH) D at least 30 ng/mL, insufficient at 21–29 ng/mL, deficient at <20 ng/mL. RESULTS: Ninety-four patients (52%) had low vitamin D levels with 74 (41%) being deficient and 20 (11%) had vitamin D insufficiency. Vitamin D deficiency was associated with 2.6-fold increased risk for COVID-19 (OR = 2.6; [95% CI 1.96–4.9]; P = 0.002. The FokI FF genotype was significantly more represented in patients compared to control group (OR = 4.05; [95% CI: 1.95–8.55]; P < 0.001). CONCLUSIONS: Vitamin D deficiency and VDR Fok I polymorphism may constitute independent risk factors for susceptibility to COVID-19 in Egyptian children and adolescents. IMPACT: Vitamin D deficiency could be a modifiable risk factor for COVID-19 in children and adolescents because of its immune-modulatory action. To our knowledge, ours is the first such study to investigate the VDR Fok I polymorphism in Caucasian children and adolescents with COVID-19. Vitamin D deficiency and the VDR Fok I polymorphism may constitute independent risk factors for susceptibility to COVID-19 in Egyptian children and adolescents. Clinical trials should be urgently conducted to test for causality and to evaluate the efficacy of vitamin D supplementation for prophylaxis and treatment of COVID-19 taking into account the VDR polymorphisms. |
format | Online Article Text |
id | pubmed-9461391 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-94613912022-09-10 Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19 Zeidan, Nancy M. S. Lateef, Hanan M. Abd El Selim, Dalia M. Razek, Suzan A. Abd-Elrehim, Ghada A. B. Nashat, Mohamed ElGyar, Noha Waked, Nevin M. Soliman, Attia A. Elhewala, Ahmed A. Shehab, Mohamed M. M. Ibraheem, Ahmed A. A. Shehata, Hassan Yousif, Yousif M. Akeel, Nagwa E. Hashem, Mustafa I. A. Ahmed, Amani A. Emam, Ahmed A. Abdelmohsen, Mohamed M. Ahmed, Mohamed F. Saleh, Ahmed S. E. Eltrawy, Heba H. Shahin, Gehan H. Nabil, Rehab M. Hosny, Thoraya A. Abdelhamed, Mohamed R. Afify, Mona R. Alharbi, Mohanned T. Nagshabandi, Mohammed K. Tarabulsi, Muyassar K. Osman, Sherif F. Abd-Elrazek, Amal S. M. Rashad, Manal M. El-Gaaly, Sonya A. A. Gad, Said A. B. Mohamed, Mohamed Y. Abdelkhalek, Khalil Yousef, Aly A. Pediatr Res Population Study Article BACKGROUND: Given the sparse data on vitamin D status in pediatric COVID-19, we investigated whether vitamin D deficiency could be a risk factor for susceptibility to COVID-19 in Egyptian children and adolescents. We also investigated whether vitamin D receptor (VDR) FokI polymorphism could be a genetic marker for COVID-19 susceptibility. METHODS: One hundred and eighty patients diagnosed to have COVID‐19 and 200 matched control children and adolescents were recruited. Patients were laboratory confirmed as SARS-CoV-2 positive by real-time RT-PCR. All participants were genotyped for VDR Fok1 polymorphism by RT-PCR. Vitamin D status was defined as sufficient for serum 25(OH) D at least 30 ng/mL, insufficient at 21–29 ng/mL, deficient at <20 ng/mL. RESULTS: Ninety-four patients (52%) had low vitamin D levels with 74 (41%) being deficient and 20 (11%) had vitamin D insufficiency. Vitamin D deficiency was associated with 2.6-fold increased risk for COVID-19 (OR = 2.6; [95% CI 1.96–4.9]; P = 0.002. The FokI FF genotype was significantly more represented in patients compared to control group (OR = 4.05; [95% CI: 1.95–8.55]; P < 0.001). CONCLUSIONS: Vitamin D deficiency and VDR Fok I polymorphism may constitute independent risk factors for susceptibility to COVID-19 in Egyptian children and adolescents. IMPACT: Vitamin D deficiency could be a modifiable risk factor for COVID-19 in children and adolescents because of its immune-modulatory action. To our knowledge, ours is the first such study to investigate the VDR Fok I polymorphism in Caucasian children and adolescents with COVID-19. Vitamin D deficiency and the VDR Fok I polymorphism may constitute independent risk factors for susceptibility to COVID-19 in Egyptian children and adolescents. Clinical trials should be urgently conducted to test for causality and to evaluate the efficacy of vitamin D supplementation for prophylaxis and treatment of COVID-19 taking into account the VDR polymorphisms. Nature Publishing Group US 2022-09-09 2023 /pmc/articles/PMC9461391/ /pubmed/36085364 http://dx.doi.org/10.1038/s41390-022-02275-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Population Study Article Zeidan, Nancy M. S. Lateef, Hanan M. Abd El Selim, Dalia M. Razek, Suzan A. Abd-Elrehim, Ghada A. B. Nashat, Mohamed ElGyar, Noha Waked, Nevin M. Soliman, Attia A. Elhewala, Ahmed A. Shehab, Mohamed M. M. Ibraheem, Ahmed A. A. Shehata, Hassan Yousif, Yousif M. Akeel, Nagwa E. Hashem, Mustafa I. A. Ahmed, Amani A. Emam, Ahmed A. Abdelmohsen, Mohamed M. Ahmed, Mohamed F. Saleh, Ahmed S. E. Eltrawy, Heba H. Shahin, Gehan H. Nabil, Rehab M. Hosny, Thoraya A. Abdelhamed, Mohamed R. Afify, Mona R. Alharbi, Mohanned T. Nagshabandi, Mohammed K. Tarabulsi, Muyassar K. Osman, Sherif F. Abd-Elrazek, Amal S. M. Rashad, Manal M. El-Gaaly, Sonya A. A. Gad, Said A. B. Mohamed, Mohamed Y. Abdelkhalek, Khalil Yousef, Aly A. Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19 |
title | Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19 |
title_full | Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19 |
title_fullStr | Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19 |
title_full_unstemmed | Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19 |
title_short | Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19 |
title_sort | vitamin d deficiency and vitamin d receptor foki polymorphism as risk factors for covid-19 |
topic | Population Study Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461391/ https://www.ncbi.nlm.nih.gov/pubmed/36085364 http://dx.doi.org/10.1038/s41390-022-02275-6 |
work_keys_str_mv | AT zeidannancyms vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT lateefhananmabdel vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT selimdaliam vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT razeksuzana vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT abdelrehimghadaab vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT nashatmohamed vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT elgyarnoha vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT wakednevinm vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT solimanattiaa vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT elhewalaahmeda vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT shehabmohamedmm vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT ibraheemahmedaa vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT shehatahassan vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT yousifyousifm vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT akeelnagwae vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT hashemmustafaia vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT ahmedamania vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT emamahmeda vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT abdelmohsenmohamedm vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT ahmedmohamedf vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT salehahmedse vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT eltrawyhebah vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT shahingehanh vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT nabilrehabm vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT hosnythorayaa vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT abdelhamedmohamedr vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT afifymonar vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT alharbimohannedt vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT nagshabandimohammedk vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT tarabulsimuyassark vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT osmansheriff vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT abdelrazekamalsm vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT rashadmanalm vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT elgaalysonyaaa vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT gadsaidab vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT mohamedmohamedy vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT abdelkhalekkhalil vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 AT yousefalya vitaminddeficiencyandvitamindreceptorfokipolymorphismasriskfactorsforcovid19 |